Key Findings:  C-phycocyanin exhibited an antihypertensive activity in an animal model of chronic kidney disease.
Type of Study:  Animal Study
Study Result:  Positive
Research Location(s):  Mexico, United Kingdom
Year of Pub:  2022
Cannabinoids Studied:  Phycocyanin
Phytocannabinoid Source:  Not Applicable
Citation:  Rojas-Franco P, et al. The Nutraceutical Antihypertensive Action of C-Phycocyanin in Chronic Kidney Disease Is Related to the Prevention of Endothelial Dysfunction. Nutrients. 2022; 14:(unknown pages). doi: 10.3390/nu14071464
Authors:  Rojas-Franco P, Garcia-Pliego E, Vite-Aquino AG, Franco-Colin M, Serrano-Contreras JI, Paniagua-Castro N, Gallardo-Casas CA, Blas-Valdivia V, Cano-Europa E